In one paragraphArticle in Epilepsia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Aristea S GalanopoulouSaul R. Korey Department of Neurology, Isabelle Rapin Division of Child Neurology, Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Montefiore/Einstein Epilepsy Center, Bronx, New York, USA.ORCID 0000-0002-0472-2903 Solomon L MoshéSaul R. Korey Department of Neurology, Isabelle Rapin Division of Child Neurology, Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Montefiore/Einstein Epilepsy Center, Bronx, New York, USA.ORCID 0000-0001-9427-9476 Heidrun PotschkaInstitute of Pharmacology, Toxicology, and Pharmacy, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0003-1506-0252 Luisa RochaPharmacobiology Department, Center for Research and Advanced Studies (CINVESTAV), Mexico City, Mexico.ORCID 0000-0003-4495-9427 Matthew C WalkerDepartment of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-0812-0352 Funding
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Public Engagement CoreU54NS100064 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ENGEL, JEROME NONE, GALANOPOULOU, ARISTEA S · 2017 to 2021
$21.7MConsequences of Prolonged Febrile Seizures in ChildhoodR01NS043209 · NINDS · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SHINNAR, SHLOMO · 2003 to 2012
$21.5MConsequences of Prolonged Febrile Seizures in ChildhoodR37NS043209 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHINNAR, SHLOMO · 2013 to 2019
$11.4MTranslational Platform for Epilepsy Therapy and Biomarker DiscoveryR01NS127524 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Denes V. Agoston, LISA D COLES · 2022 to 2026
$11.0MSUPPORT FOR THE ROSE F KENNEDY IDDRC P50P50HD105352 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Julie Secombe · 2021 to 2026
$7.0MNICHD NIH HHS P50 HD105352NINDS NIH HHS R01 NS043209NINDS NIH HHS R01 NS127524NINDS NIH HHS R37 NS043209NINDS NIH HHS U54 NS100064
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
EpilepsyDrug ResistanceHumans
Identifiers
PMID37921052
PMCPMC10842693
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390